Products

What will AGI do for Benznidazole?

This classification denotes an antiprotozoal agent with the molecular formula C12H12N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YC42NRJ1ZD, chemically known as 1h-imidazole-1-acetamide, 2-nitro-n-(phenylmethyl)- (9ci) but generally known as benznidazole, which bears US NIH Compound Identifier 31593. European Medicines Agency schedules Benznidazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05753MIG. The term BENZNIDAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). World Health Organization schedules benznidazole in its Anatomical Therapeutic Chemical (ATC) Classification. BENZNIDAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule benznidazole under HS 29332990 and SITC 51573. As of Q4 2014, BENZNIDAZOLE remains the US FDA Preferred Term for this commodity. Benznidazole bears US NLM identifiers UMLS ID C0053230 and NCI Concept Code C1013. SMILES: C1=CC=C(C=C1)CNC(=O)CN2C=CN=C2[N+](=O)[O-].